Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Depreciation and Depletion (2010 - 2016)

Grifols' (GRFS) quarterly Depreciation and Depletion came in at $55.6 million in Q3 2016, up 2.76% YoY from $54.1 million in Q4 2015, and little changed on a QoQ basis from $55.8 million in Q4 2015.

Grifols (GRFS) Depreciation and Depletion (2010 - 2016) Analysis & Trends

Grifols (GRFS) has 7 years of Depreciation and Depletion data on file, last reported at $55.6 million in Q3 2016.

  • Quarterly Depreciation and Depletion rose 2.76% year-over-year to $55.6 million in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $217.0 million (down 0.69% YoY) and the FY2015 annual result came in at $210.8 million, down 16.31% from the prior year.
  • Depreciation and Depletion was little changed at $55.6 million in Q3 2016, from $55.8 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $183.8 million in Q3 2014 to a low of -$63.5 million in Q2 2014.
  • A 5-year average of $50.0 million and a median of $43.5 million in 2013 frame the typical range for Depreciation and Depletion.
  • The widest YoY moves for Depreciation and Depletion: up 329.0% in 2014, down 246.5% in 2014.
  • Tracing GRFS's Depreciation and Depletion over 5 years: stood at $41.2 million in 2012, then climbed by 5.4% to $43.5 million in 2013, then soared by 46.47% to $63.7 million in 2014, then decreased by 12.28% to $55.8 million in 2015, then declined by 0.38% to $55.6 million in 2016.
  • The last three Depreciation and Depletion figures came in at $55.6 million (Q3 2016), $55.8 million (Q4 2015), and $54.1 million (Q3 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2016 55.63 Mn
Sep 30, 2016 55.63 Mn
Dec 31, 2015 55.85 Mn
Dec 31, 2015 55.85 Mn
Sep 30, 2015 54.14 Mn
Sep 30, 2015 54.14 Mn
Jun 30, 2015 51.35 Mn
Jun 30, 2015 51.35 Mn
Mar 31, 2015 49.33 Mn
Mar 31, 2015 49.33 Mn
Dec 31, 2014 63.66 Mn
Dec 31, 2014 63.66 Mn
Sep 30, 2014 183.76 Mn
Sep 30, 2014 183.76 Mn
Jun 30, 2014 -63.47 Mn
Jun 30, 2014 -63.47 Mn
Mar 31, 2014 63.52 Mn
Mar 31, 2014 63.52 Mn
Dec 31, 2013 43.47 Mn
Dec 31, 2013 43.47 Mn